TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Duchenne Drug Developer (Not Sarepta) Hit With Lengthy FDA Delay
STOCKS

Mimedx goes after Osiris with lawsuit

  • By Alicia McElhaney
  • May 19, 2016 10:47 AM EDT
It's Almost Unbelievable This Private Equity Firm Has Reportedly Offered $7 Billion to Buy Staples
OPINION

Buy these five breakout stocks now for big gains.

  • By Roberto Pedone
  • Jan 8, 2016 8:40 AM EST
New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Osiris Therapeutics (OSIR) Weak On High Volume Today

  • By TheStreet Wire
  • Nov 18, 2015 10:06 AM EST
'Mad Money' Lightning Round: If You Like Tesla Cars, Buy the Stock
JIM CRAMER

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

  • By Margo Beller
  • Oct 15, 2015 6:00 AM EDT
Jim Cramer's 'Mad Money' Recap: Industrials, Oil, Tech Stocks Rising at Last
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Be Patient, Then Start Buying

  • By Scott Rutt
  • Oct 14, 2015 8:05 PM EDT
Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
MARKETS

Trade-Ideas: Osiris Therapeutics (OSIR) Is Today's Strong And Under The Radar Stock

  • By TheStreet Wire
  • Aug 3, 2015 10:05 AM EDT
Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

Strong And Under The Radar: Osiris Therapeutics (OSIR)

  • By TheStreet Wire
  • Jun 17, 2015 10:04 AM EDT
'Mad Money' Lightning Round: Take General Mills Over Kellogg
JIM CRAMER

'Mad Money' Lightning Round: Buy Disney, Be Careful With Exelixis

  • By Scott Rutt
  • May 23, 2015 6:00 AM EDT
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's My Game Plan for Next Week

  • By Scott Rutt
  • May 22, 2015 8:43 PM EDT
Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

Don't Miss Today's Strong And Under The Radar Stock: Osiris Therapeutics (OSIR)

  • By TheStreet Wire
  • May 19, 2015 11:35 AM EDT
Dick's Sporting Goods (DKS) Stock Declines Pre-Market on Weak First Quarter SSS
MARKETS

Osiris Therapeutics (OSIR) Upgraded From Sell to Hold

  • By TheStreet Quant Ratings
  • Feb 25, 2015 12:20 PM EST
3 Unusual-Volue Stocks on the Rise
INVESTING

5 Unusual Stocks Moving on Unusual Volume

  • By Roberto Pedone
  • Aug 12, 2014 9:19 AM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING

3 Stocks Spiking on Unusual Volume

  • By Roberto Pedone
  • May 15, 2014 9:46 AM EDT
5 Heavily Shorted Stocks Set to Soar on Bullish Earnings
INVESTING

3 Big-Volume Stocks in Breakout Territory

  • By Roberto Pedone
  • Apr 7, 2014 9:24 AM EDT
Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Osiris Therapeutics Inc. Stock Downgraded (OSIR)

  • By Kevin Baker
  • Mar 17, 2014 12:07 PM EDT
Jones Lang LaSalle (JLL) Reaches New Lifetime High Today
MARKETS

Osiris Therapeutics Inc. Stock Downgraded (OSIR)

  • By Kevin Baker
  • Mar 7, 2014 10:14 AM EST
Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Biotech Stock Mailbag: NeoStem, MannKind, Inovio

  • By Adam Feuerstein
  • Jan 10, 2014 6:00 AM EST
AirMedia Group (AMCN) In A Perilous Reversal
MARKETS

Osiris Therapeutics Inc. Stock Upgraded (OSIR)

  • By Kevin Baker
  • Dec 6, 2013 10:13 AM EST
5 Stocks Poised for Breakouts
INVESTING

5 Stocks Poised for Breakouts

  • By Roberto Pedone
  • Dec 2, 2013 11:00 AM EST
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Osiris Therapeutics Inc. Stock Downgraded (OSIR)

  • By Kevin Baker
  • Nov 1, 2013 11:10 AM EDT
CTI Biopharma Posts Positive Myelofibrosis Study Results
STOCKS

FDA Slaps Osiris For Misleading Medical Claims About Stem-Cell Bandage (Update 1)

  • By Adam Feuerstein
  • Oct 23, 2013 11:10 AM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: Bubble Debate, Cel-Sci, Zogenix, Zalicus

  • By Adam Feuerstein
  • Oct 4, 2013 6:00 AM EDT
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Biotech Stock Mailbag: Merrimack, Rockwell, Prosensa, Osiris

  • By Adam Feuerstein
  • Sep 6, 2013 6:00 AM EDT
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Biotech Stock Mailbag: MannKind, Osiris, BioCryst, Vical, Amarin

  • By Adam Feuerstein
  • Aug 23, 2013 5:30 AM EDT
5 Hated Earnings Stocks You Should Love
INVESTING

4 Biotech Stocks Rising on Unusual Volume

  • By Roberto Pedone
  • Aug 20, 2013 9:02 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.